A Study of Improved Efficacy, Safety and Compliance to Administer Insulin in Pen vs. Vial and Syringe
- Conditions
- Diabetes
- Interventions
- Device: Insulin Pen Device
- Registration Number
- NCT01857375
- Lead Sponsor
- Northwell Health
- Brief Summary
This research is to determine the use of insulin pens compared to syringe and vial therapy in adults newly begun on insulin therapy during their hospital stay.
- Detailed Description
This research is to determine the use of insulin pens compared to syringe and vial therapy in adults newly begun on insulin therapy during their hospital stay. Patients will have no prior experience using insulin or other self-administered injectable medicine. The study will examine which method of administering insulin reduces dosing errors, causes a lower incidence of low blood sugars, increases adherence to therapy and with which method patients are more satisfied.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 35
- Adult in hospital and diagnosed with diabetes; must have no prior experience using insulin or other self-administered injectable medicine. they must be able to prepare an injection and to self administer the insulin using either a pen device or syringe and vial. They must be willing to monitor their blood sugar three times per day and keep a diary of their sugar measurements and insulin doses.
- Previously treated with injectable medicine
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Insulin Pen Insulin Pen Device Patients receiving insulin via insulin pen
- Primary Outcome Measures
Name Time Method Insulin Dosing Accuracy (in units) Approximately one year Whether the method of administering insulin would: 1) reduce dosing errors as measured by direct observation of patient performance, 2) reduce the risk of hypoglycemia, 3) increase adherence to insulin, 4) improve patient satisfaction.Dosing accuracy was measured by direct observation of subject's performance at follow-up visits.
- Secondary Outcome Measures
Name Time Method Adherence to prescribed dose of insulin (assess patient diaries and observation of used pens/vials) 3 months Reduce the Risk of hypoglycemia (assessed by patient diary) 3 months Patient satisfaction with method of insulin administration measured by questionnaire. 3 months